Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy? [Phase 4]
Phase 4 trial exploring eradication of Helicobacter pylori during pregnancy and its impact on iron replacement therapy.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment [Phase 4]
A Phase 4 clinical trial evaluated high-dose dual therapy plus bismuth for Helicobacter pylori infection and has completed.
-
FDA approval · 2018-11-05FDA Approved: OMEPRAZOLE — Original Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' original ANDA for a generic omeprazole product. Omeprazole is a proton pump inhibitor indicated for gas…
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults [Phase 4]
Phase 4 trial update analyzing the impact of Helicobacter pylori infection on the salivary microbiome in adults.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication [Phase 4]
Phase 4 trial investigating probiotics to reduce adverse effects and dysbiosis during Helicobacter pylori eradication therapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori [Phase 4]
Phase 4 clinical trial comparing genotypic resistance-guided therapy to susceptibility-tested guided therapy for first-line eradication of H…
-
FDA approval · 2018-10-05FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination of bismuth subitrate potassium, metronidazole, and tetracycline hydrochloride (H…
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy [Phase 4]
A Phase 4 trial update suggests a doxycycline- and furazolidone-containing quadruple regimen is superior to tailored therapy for Helicobacte…
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication [Phase 4]
Phase 4 clinical trial assessing how CYP2C19 genetic variation affects Helicobacter pylori eradication therapy.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment [Phase 4]
Phase 4 trial comparing tailored versus empiric therapy for Helicobacter pylori infection has been completed.
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Tailored Therapy for Helicobacter Pylori Rescue Treatment [Phase 4]
Phase 4 trial update on tailored therapy for Helicobacter pylori rescue treatment.
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)
This document provides an update on a prospective cohort trial evaluating early detection and screening strategies for gastric cancer in Sic…
-
FDA approval · 2018-07-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for Esomeprazole Magnesium. This approval authorizes the marketi…
-
FDA approval · 2018-07-20FDA Approved: OMEPRAZOLE — Original Application (INNOVUS PHARMACEUTICALS, INC.)
FDA approved a generic version of omeprazole (omeprazole and omeprazole magnesium) under ANDA210593 from Innovus Pharmaceuticals.
-
CLINICAL_TRIALS research · 2018-07-11Clinical Trial Update: The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.
An update on a clinical trial assessing how antibiotic minimum inhibitory concentration (MIC) values affect the efficacy of treatment regime…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics [Phase 3]
Phase 3 clinical trial update for a pediatric urea breath test system (BreathID Hp) assessing diagnosis of Helicobacter pylori infection; st…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication. [Phase 4]
Phase 4 clinical trial update comparing antimicrobial susceptibility testing-guided therapy to empirical therapy for first-line eradication …
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment [Phase 4]
Phase 4 clinical trial evaluating clarithromycin-based triple therapy plus bismuth as first-line treatment for Helicobacter pylori infection…
-
CLINICAL_TRIALS research · 2018-06-13Clinical Trial Update: Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection [Phase 4]
Phase 4 clinical trial is evaluating genotypic resistance-guided therapy for refractory Helicobacter pylori infection.
-
FDA approval · 2018-06-12FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
FDA approved a supplemental application for BERKLEY AND JENSEN OMEPRAZOLE (omeprazole) submitted by BJWC.
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole from Sandoz Inc, enabling the continued marketing of the generic omeprazole produ…
-
FDA approval · 2018-06-07FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
The FDA approved a supplemental application for Esomeprazole Strontium submitted by R2 Pharma, LLC under NDA202342.
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for the generic Omeprazole from Lannett Company, Inc., granting continued approval for this prod…
-
CLINICAL_TRIALS research · 2018-06-04Clinical Trial Update: Sequential Versus Quadruple Therapy in the Second-line Treatment [Phase 4]
Phase 4 clinical trial update comparing sequential versus quadruple therapy as second-line treatment for Helicobacter pylori infection; the …
-
FDA approval · 2018-05-31FDA Approved: OMEPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for omeprazole from Dr. Reddy's Laboratories Limited under the ANDA pathway.